Current Report Filing (8-k)
December 30 2022 - 8:47AM
Edgar (US Regulatory)
0001630212
false
0001630212
2022-12-29
2022-12-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 29, 2022
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-38728 |
|
47-1685128 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
4400 Route 9 South, Suite 3100, Freehold, New
Jersey 07728
(Address of principal executive offices) (zip code)
646-762-4517
(Registrant's telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbols |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value per share |
|
AVCO |
|
The Nasdaq Capital Market |
Item 5.07 Submission of Matters to a Vote of Security Holders
Avalon GloboCare Corp. (the
"Company") held its Annual Meeting on December 29, 2022. Of the 99,984,439 shares of Common Stock outstanding on November 15,
2022, the record date, 71,284,782 shares were represented at the Annual Meeting, in person or by proxy, constituting a quorum. The proposals
considered at the Annual Meeting are described in detail in the Proxy Statement. The proposals described below were voted upon at the
Annual Meeting and the number of votes cast with respect to each proposal was as set forth below:
(1) Elect six directors
until his successor is duly elected and qualified, or until his earlier death, resignation or removal. The six directors receiving the
highest vote were appointed to the board. The following Directors were elected to the board.
| |
For | | |
Withheld | |
Wenzhao “Daniel” Lu | |
| 53,982,841 | | |
| 590,963 | |
David Jin, MD, PhD | |
| 54,000,145 | | |
| 573,659 | |
Steven A. Sanders | |
| 53,931,438 | | |
| 642,366 | |
Wilbert J. Tauzin, II | |
| 53,984,652 | | |
| 589,152 | |
William B. Stilley, III | |
| 53,939,369 | | |
| 634,435 | |
Tevi Troy | |
| 53,939,946 | | |
| 633,858 | |
(2) Ratify the appointment
of MARCUM LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022. This matter was determined
based on majority of the shares cast.
For |
|
Against |
|
Abstain |
71,144,419 |
|
77,386 |
|
62,977 |
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AVALON GLOBOCARE CORP. |
|
|
Dated: December 30, 2022 |
By: |
/s/ Luisa Ingargiola |
|
|
Name: |
Luisa Ingargiola |
|
|
Title: |
Chief Financial Officer |
2
Avalon GloboCare (NASDAQ:ALBT)
Historical Stock Chart
From Jan 2025 to Feb 2025
Avalon GloboCare (NASDAQ:ALBT)
Historical Stock Chart
From Feb 2024 to Feb 2025